Jaime Bartushak - Oct 10, 2023 Form 4 Insider Report for Citius Pharmaceuticals, Inc. (CTXR)

Role
Chief Financial Officer
Signature
/s/ Alexander M. Donaldson, by power of attorney
Stock symbol
CTXR
Transactions as of
Oct 10, 2023
Transactions value $
$0
Form type
4
Date filed
10/12/2023, 04:15 PM
Previous filing
Oct 6, 2022
Next filing
Aug 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CTXR Common Stock 60.4K Oct 10, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTXR Stock Option (Right to Purchase Common Stock) Award $0 +300K $0.00 300K Oct 10, 2023 Common Stock 300K $0.70 Direct F1
holding CTXR Stock Option (Right to Purchase Common Stock) 300K Oct 10, 2023 Common Stock 300K $1.25 Direct F2
holding CTXR Stock Option (Right to Purchase Common Stock) 300K Oct 10, 2023 Common Stock 300K $2.04 Direct F3
holding CTXR Stock Option (Right to Purchase Common Stock) 100K Oct 10, 2023 Common Stock 100K $2.00 Direct F4
holding CTXR Stock Option (Right to Purchase Common Stock) 125K Oct 10, 2023 Common Stock 125K $1.01 Direct F5
holding CTXR Stock Option (Right to Purchase Common Stock) 100K Oct 10, 2023 Common Stock 100K $0.67 Direct F6
holding CTXR Stock Option (Right to Purchase Common Stock) 70K Oct 10, 2023 Common Stock 70K $1.62 Direct F7
holding CTXR Stock Option (Right to Purchase Common Stock) 25K Oct 10, 2023 Common Stock 25K $3.45 Direct F8
holding CTXR Stock Option (Right to Purchase Common Stock) 48.3K Oct 10, 2023 Common Stock 48.3K $10.50 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date.
F2 The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date.
F3 The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date.
F4 The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date.
F5 The options vested in full on October 6, 2023.
F6 The options vested in full on October 8, 2022.
F7 The options vested in full on September 4, 2021.
F8 the options vested in full on September 12, 2020.
F9 The options vested in full on July 7, 2019.